Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 6/20 | 0.64 |
| ▸ | BRD2 | P25440 | 6/20 | 0.64 |
| ▸ | BRD3 | Q15059 | 6/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17517792 | 0.92 | BRD4 (0.64) | BRD4BRD2BRD3 | |
| SCHEMBL5837342 | 0.92 | BRD4 (0.64) | BRD4BRD2BRD3 | |
| SCHEMBL5837340 | 0.92 | BRD4 (0.64) | BRD4BRD2BRD3 | |
| SCHEMBL224018 | 0.91 | BRD4 (0.74) | BRD4BRD2BRD3 | |
| SCHEMBL5836515 | 0.91 | BRD4 (0.74) | BRD4BRD2BRD3 | |
| SCHEMBL17503199 | 0.91 | BRD4 (0.74) | BRD4BRD2BRD3 | |
| SCHEMBL17503200 | 0.91 | BRD4 (0.74) | BRD4BRD2BRD3 | |
| SCHEMBL17503201 | 0.91 | BRD4 (0.74) | BRD4BRD2BRD3 | |
| SCHEMBL13178434 | 0.88 | BRD4 (0.65) | BRD4BRD2BRD3 | |
| SCHEMBL2741201 | 0.88 | BRD4 (0.58) | BRD4BRD2BRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120004197-A1 | PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR ANEMIA COMPRISING TETRAHYDROQUINOLINE COMPOUND AS ACTIVE INGREDIENT | KOWA COMPANY, LTD. (JP) | 2012-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120004197-A1 | PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR ANEMIA COMPRISING TETRAHYDROQUINOLINE COMPOUND AS ACTIVE INGREDIENT | EPOR, HBG1, HBG2 | BRD4 861/4885BRD2 1499/4885BRD3 1556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.